Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001123292-09-000577

Director sold 149,208 shares at an average $4.08 ($608,228)

From the SEC's structured data for this filing

Trades in this filing

Lowe David George · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2009-06-08 Sale : show line 1 in the form −65,708 $4.21 $276,388 469,500 I
2009-06-09 Sale : show line 2 in the form −47,500 $3.99 $189,392 422,000 I
2009-06-10 Sale : show line 3 in the form −36,000 $3.96 $142,448 386,000 I
Open-market sales · 149,208 sh · avg $4.08 · $608,228
Loading xslF345X03/edgar.xml…